-+ 0.00%
-+ 0.00%
-+ 0.00%

Addex Therapeutics delays annual Form 20-F filing after financial statement completion setback

PUBT·04/30/2026 20:03:17
Listen to the news
Addex Therapeutics delays annual Form 20-F filing after financial statement completion setback
  • Addex Therapeutics reported a delay in filing its annual report on Form 20-F for fiscal year 2025 ended Dec. 31, 2025.
  • Filing was delayed due to more time needed to complete financial statements and related disclosures.
  • Addex expects to file Form 20-F as soon as practicable, no later than 15 calendar days after prescribed due date.
  • Separate results update showed net loss of CHF 6.7 million for 2025 versus net profit of CHF 7.1 million in 2024.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Addex Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-052854), on April 30, 2026, and is solely responsible for the information contained therein.